tk88 bet

COVID-19 downgraded to Group B infectious disease

COVID-19 is no longer an infectious disease in Group A but downgraded to Group B from October 20, according to a decision issued on October 19 by the Ministry of Health (MoH).
COVID-19 downgraded to Group B infectious disease ảnh 1A health worker collects sample for COVID-19 testing. (Photo: VNA)
Hanoi (VNA) – COVID-19 isno longer an infectious disease in Group A but downgraded to Group B fromOctober 20, according to a decision issued on October 19 by the Ministry ofHealth (MoH).

With the downgrade, based on Point bof Clause 1 and Clause 2 of Article 3 in the 2007 Law on Prevention and Controlof Infectious Diseases, COVID-19 prevention and control activities will becarried out in line with the regulations on Group B ones.
 
On January 29, 2020, the MoH classified the coronavirus disease 2019 as a GroupA infectious disease.

According to the 2007 law, Group A comprisesparticularly dangerous infectious diseases that can spread very fast and on alarge scale and have a high mortality rate or unclear causes. Meanwhile, GroupB covers the infectious diseases that can spread fast and cause death.

Recently, Deputy Prime Minister TranHong Ha signed a decision amending an appendix that regulates the incubationperiod and the required period of no new infections to serve as the basis for declaringend to an infectious disease outbreak. This appendix accompanies the PrimeMinister’s Decision No 02/2016/QD-TTg, dated January 28, 2016, on theconditions to declare an outbreak and end to an outbreak of an infectiousdisease.

In the amended appendix, COVID-19 is aGroup B infectious disease which has an incubation period of four days. Thetime with no new cases needed to declare an outbreak end is eight days. The earlier regulations put the respectiveperiods at 14 days and 28 days.

Thereduction of the periods was based on the scientific ground, the currentsituation of the pandemic, and recommendations from the World HealthOganisation (WHO) and the US Centres for Disease Control and Prevention.

Sincethe pandemic broke out, Vietnam has undergone four waves of COVID-19 infectionswith 11,624,065 cases, ranking 13th among 231 countries and territories.With an average of 117,470 cases per 1 million people, it ranks 120th in this regard.

Amongthe infections, it has recorded 10,640,953 recoveries and 43,206 deaths,accounting for 0.4% of the total.

Thecountry has administered 266,532,582 doses of COVID-19 vaccine so far,statistics show./.
VNA

See more

Assoc. Prof. Dr Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi, speaks online on Vietnam’s digital transformation strategy in medical education. (Photo: VNA)

🍌 Forum spotlights AI and digital innovation in healthcare

To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
A banner on the side of a car urges people to quit smoking for their own health and that of their loved ones (Photo: VNA)

✨ Sharp tobacco tax hike urged to safeguard youths, community health

A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
On the morning of May 26, 2025, following bilateral talks at the Presidential Palace, President Luong Cuong (first, right) and French President Emmanuel Macron (first, left) witness the exchange of cooperation documents between leaders of ministries, agencies, and enterprises from both countries. In the photo: Ngo Chi Dung, General Director and Chairman of the Board of Viet Nam Vaccine Company (VNVC) (second, right), and Zainab Sadat Qayyum, President of Sanofi Southeast Asia – India, exchange the cooperation agreement on the transfer of Sanofi’s vaccine production technology to VNVC’s vaccine and biologicals plant. (Photo: VNVC)

♍ Vietnam, France collaborate in vaccine production technology transfer

Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|